Pasturan, Cymryel Gold .
HRN: 24-94-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/10/2024
04/16/2024
IV
50mg
Q24h
Late Onset Sepsis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes